跳至主要内容
临床试验/NCT07317843
NCT07317843招募中不适用

Home-Based Passive Heat Therapy-Towards a Scalable Intervention to Improve Cardiovascular Health in Persons With Spinal Cord Injury

The University of Texas Health Science Center at San Antonio1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2026年3月24日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
48
试验地点
1
主要终点
Laser Doppler Flowmetry (LDF)

研究概览

简要总结

The study is designed to investigate the effects of passive heat therapy on blood vessel health in 40 people (48 enrolled with attrition rate of 20%). Following an extensive set of vascular function tests, participants will engage in either a passive heat therapy intervention for 60 minutes, 4 times a week for 8 weeks, or a placebo intervention at a lower temperature. Seven of the 8 weeks of intervention will occur in the home setting. Vascular function tests will be repeated after the 8 weeks to determine if chronic passive heat stress improved vascular health.

详细描述

The experimental arm (HEAT) participants undergo an 8-week intervention with 4 weekly passive heat therapy sessions. The aim of each session is to raise the participants' core temperature by at least 1°C by resting under heating blankets set at approximately 42°C. The control arm (SHAM) participants undergo the same procedure as above except the temperature setting of the blankets is lower at approximately 34°C.

Screening, baseline assessments and the first 4 sessions will be conducted in the investigator's SCI lab to familiarize the participant with how to apply the heating blankets and ensure safety. After the 4th session, participants will receive a heating blanket for use at home in the remaining 7 intervention weeks. Cardiac MRI and peripheral vascular assessments are performed at baseline and within two weeks after completing the intervention. Weekly sessions (4x per week) in weeks 2 to 8 will be performed at home and secure VA-approved online video conferencing software will be used by study staff to remotely supervise the sessions and collect data.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participant demonstrates understanding of the study and has provided an appropriately signed and dated informed consent.
  • Participants will be male or female, 18-60 years of age, at the time of Visit
  • Female participants must be non-lactating. Female patients are eligible only if they have a negative pregnancy test throughout the study period (or are postmenopausal). Postmenopausal women taking hormone replacement will be included if they have been on a stable dose for =6 months.
  • Stable SCI (AIS A or B) of longer than 1-year duration.
  • Use of medications for clinical management of medical problems directly related to SCI is not considered an exclusion criterion. Status such as detrusor instability, muscle spasms, and other common SCI problems (other than those that could alter vascular responsiveness) may be allowed for those SCI participants who have been on stable doses for =6 months. Results from participants taking such medications will be analyzed to determine possible medication-related differences from those on no medications.

排除标准

  • Participants who smoke, or:
  • Uses daily administration of anti-inflammatory medications (stable doses of NSAIDs or statins are acceptable; steroids are exclusionary)
  • Uses daily administration of vasoactive medications (e.g., alpha antagonists or agonists or phosphodiesterase inhibitors).
  • Has a current pressure ulcer or skin breakdown.
  • Has an active, uncontrolled, autoimmune or inflammatory disorder
  • Has no history of or current alcohol or substance use disorder
  • Has a history of heat related illness (e.g., heat stroke)
  • Has a history of any illness that, in the opinion of the study investigator, might confound the results of the study or poses an additional risk to the participant by their participation in the study. This includes, but is not limited to, a clinically relevant medical or surgical history.
  • Is unlikely to cooperate with the requirements of the study.

研究组 & 干预措施

HEAT

Experimental

The experimental arm (HEAT) participants undergo an 8-week intervention with 4 weekly passive heat therapy sessions (home based for 7 of 8 weeks) using an electrical heating blanket at a temperature of 42 degrees C.

干预措施: HEAT - Passive Heat Therapy (Other)

SHAM

Sham Comparator

For participants in SHAM, the heating blankets will be warm (~34°C) but will not reach a temperature that elevates core temperature. As in the HEAT arm, sessions will be home based for 7 of 8 weeks.

干预措施: Sham (No Treatment) (Other)

结局指标

主要结局

Laser Doppler Flowmetry (LDF)

时间窗: From baseline to end of treatment at 8 weeks

Measure of skin blood flow due to local skin heating

次要结局

  • Endothelial Peripheral Arterial Tone (EndoPAT)(Baseline to end of treatment at 8 weeks)
  • Cardiac MRI(Baseline to end of treatment at 8 weeks)
  • Venous Occlusion Plethysmography (VOP)(From baseline to end of treatment at 8 weeks)

研究者

申办方类型
Other
责任方
Sponsor
主要研究者

Michelle Trbovich

Professor

South Texas Veterans Health Care System

研究点 (1)

Loading locations...

相似试验